Skip to content

San Bernardino Sun

50°F
Tuesday, January 20th 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.460 -0.040 (-2.67%)
Streaming Delayed Price Updated: 9:56 AM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Bionano Genomics Stock Is a Low-Priced Bet on Sound Science ↗
Even though BNGO stock investors struggled in 2021, prepare for new price discovery as Bionano pushes the envelope in optical genome mapping. 
Via InvestorPlace
News headline image
The Critics Are Wrong About Bionano Stock ↗
The critics of Bionano are greatly underestimating the vast potential of Saphyr and of BNGO stock for long-term investors. 
Via InvestorPlace
News headline image
This Analyst’s Saphyr Calculations Suggest Buying Bionano While It’s Down ↗
If BNGO stock reaches Oppenheimer’s price target, investors are looking at a return of more than 300%, plus long-term growth potential. 
Via InvestorPlace
News headline image
5 Penny Stocks Insiders Are Buying ↗
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ... 
Via Benzinga
News headline image
Bionano Genomics Proves Not Everything Genetic is Gold ↗
Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes. 
Via InvestorPlace
Unusual Options Activity Insight: Bionano Genomics ↗
Bionano Genomics (NASDAQ:BNGO) shares experienced unusual ... 
Via Benzinga
News headline image
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ: 
Via Benzinga
News headline image
Wait for Bionano Stock to Fall Further Before Buying ↗
BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term. 
Via InvestorPlace
News headline image
Bionano’s Is on Track for Growth Thanks to Saphyr ↗
BNGO stock beats analyst forecasts yet again. Flush with cash and with Saphyr installations rising, this stock remains a high potential play. 
Via InvestorPlace
News headline image
With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here ↗
Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy. 
Via InvestorPlace
News headline image
Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript ↗
BNGO earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... 
Via Benzinga
News headline image
2 Best Biotech Stocks to Buy in November ↗
Bionano Genomics and Ocugen could both be gearing up for a healthy rally this month. 
Via The Motley Fool
News headline image
Bionano Genomics Is Still Set to Pay Off Big for Patient Investors ↗
BNGO stock is no longer a fast money trade. But that's hardly a reason to skip out on it, given its massive potential. 
Via InvestorPlace
News headline image
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive ↗
On CNBC’s "Mad Money Lightning Ro... 
Via Benzinga
News headline image
Bionano Genomics’ Latest Software Business Acquisition Adds Immense Value ↗
BNGO stock isn't a darling of the markets at the moment, but Bionano continues to advance its stature in the optical genome mapping niche. 
Via InvestorPlace
News headline image
Bionano Genomics Stock Looks Ready to Reward Patient Investors ↗
BNGO stock is down 25% since year to date. But as the company begins to deliver consistent revenue, a prudent investment may be rewarded. 
Via InvestorPlace
News headline image
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
News headline image
What's Up With Bionano Genomics Today? ↗
Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for analysis,... 
Via Benzinga
News headline image
BNGO Stock: The Big Acquisition News Sending Bionano Genomics Soaring ↗
Bionano has just made a deal that will help it secure a spot among biotech companies riding the wave of the current boom. BNGO stock is up. 
Via InvestorPlace
News headline image
Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever ↗
Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock. 
Via InvestorPlace
News headline image
BNGO Stock: What Is Driving Bionano Genomics Higher Today? ↗
Today, investors in Bionano Genomics and BNGO stock are cheering some positive clinical trial data around optical genome mapping. 
Via InvestorPlace
News headline image
Bionano Genomics Remains Promising With Global Product Adoption ↗
BNGO stock has been stuck in a range, but its next move should be to the upside based on Bionano's breakthrough genome mapping system. 
Via InvestorPlace
News headline image
If You Invested $1,000 In BioNano Stock One Year Ago, Here's How Much You'd Have Now ↗
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 37.1... 
Via Benzinga
Topics Stocks
News headline image
The Price Is Right for BioNano Genomics Given Saphyr’s Potential ↗
With its Saphyr system seeing adoption ramp up, the long-term growth potential for BNGO stock is considerable. 
Via InvestorPlace
News headline image
Bionano Stock Will Soar as the Company’s Diagnostic System Catches On ↗
As more payors reimburse labs for using Bionano's Saphyr device, the company's financial results will improve, lifting BNGO stock. 
Via InvestorPlace
News headline image
Faster and Better Clinical Outcomes Make the Case for Bionano Genomics ↗
Bionano Genomics is mastering the science of genome mapping, while a reduced-price BNGO stock has a clear path forward for investors. 
Via InvestorPlace
News headline image
Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript ↗
BNGO earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.